Giants of Cancer Care® Program Inductees
BREAST CANCER
Gabriel N. Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
- Developed and promoted the use of presurgical chemotherapy in patients with large tumors, reducing the tumors to 50% of their size prior to surgery and enabling subsequent surgical removal
- Involved in the drug development of anthracyclines and taxanes in breast cancer therapy
- Established the role of bisphosphonates in the management of bone metastases from breast cancer
- Developed gene therapy approaches to breast cancer, and played a role in the initial development of gene expression profiling and its prognostic and predictive application in breast cancers
- Past president of the American Society of Clinical Oncology
- Chair of the Southwest Oncology Group since 2007
- Recipient of numerous awards, including the 2012 William L. McGuire Award and Memorial Lecture, CTCR-AACR San Antonio Breast Cancer Symposium, and the 1997 Brinker International Award for Clinical Research
Home
SUPPORTED BY
